Friday, 29 August 2014
Last updated 2 hours ago
Oct 5 2006 | 2:37pm ET
Former IBM executive Caroline Kovac has joined Burrill & Company as a managing director. The San Francisco-based merchant bank and venture capital firm is a life-sciences specialist; Kovac—a chemistry Ph.D.—was responsible for the strategic direction of IBM’s global healthcare and life sciences division.
“Carol’s expertise and experience in growing IBM’s life sciences business into a multi-billion dollar enterprise is a tremendous addition to our life-sciences team,” CEO G. Steven Burrill said.
Kovac will develop and execute strategies in personal medicine, information technology in healthcare, stem-cell research, medical devices and diagnostics, and bio-nanotechnology.
Aug 25 2014 | 11:21am ET
As many of you know, FINalternatives was recently acquired by the owners of Futures magazine, a firm called The Alpha Pages LLC. Today marks the soft-launch of a new sister site for both publications. As its name suggests, The Alpha Pages will cover all types of alternative investments, going far beyond the more well-known ones such as hedge funds and private equity. Read more…
Commodities/Futures magazine launched at the precipice of a revolution in the futures industry—really a revolution in the idea of risk management—that would move it from a small niche industry to ...